首页 | 本学科首页   官方微博 | 高级检索  
     

直肠黏膜推移皮瓣术治疗高位复杂性肛瘘的临床疗效观察
引用本文:赵亮,袁和学,张睿. 直肠黏膜推移皮瓣术治疗高位复杂性肛瘘的临床疗效观察[J]. 中华结直肠疾病电子杂志, 2022, 11(1): 54-58. DOI: 10.3877/cma.j.issn.2095-3224.2022.01.008
作者姓名:赵亮  袁和学  张睿
作者单位:1. 110000 辽宁省沈阳市肛肠医院肛门病五疗区2. 110000 辽宁省沈阳市肛肠医院肛门病三疗区3. 110000 沈阳市,辽宁省肿瘤医院结直肠外科
基金项目:辽宁省自然科学基金项目(2020-MS-324)
摘    要:目的观察直肠黏膜推移皮瓣术(ERAF)在治疗高位复杂性肛瘘(HCAF)中的临床疗效。 方法选取80例高位复杂性肛瘘的患者,随机将其分为观察组40例和对照组40例,观察组采用ERAF、对照组采用松弛挂线术(LST),分析比较两组患者的临床疗效、视觉模拟疼痛评分(VAS)、肛门功能失禁(Wexner)评分、术后复发率。 结果两组患者术后第1天VAS评分比较(t=-1.268,P>0.05)、术后1年复发率比较(χ2=1.829,P>0.05),差异均无统计学意义;两组患者住院时间比较(t=-16.464,P<0.05)、伤口愈合时间比较(t=-12.662,P<0.05)、术后6个月Wexner评分比较(t=-34.785,P<0.05)、术后第5天VAS评分比较(t=-8.222,P<0.05)、术后第7天VAS评分比较(t=-6.056,P<0.05),差异均具有统计学意义。 结论ERAF可使患者住院时间及伤口愈合时间缩短,减轻患者术后疼痛,肛门失禁评分亦优于LST术式,值得临床中广泛应用。

关 键 词:  直肠黏膜推移皮瓣术  高位复杂性肛瘘  临床疗效  
收稿时间:2020-11-30

Clinical effect obesrvation of the treatment of high complex anal fistula with endorectal advancement flap
Liang Zhao,Hexue Yuan,Rui Zhang. Clinical effect obesrvation of the treatment of high complex anal fistula with endorectal advancement flap[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(1): 54-58. DOI: 10.3877/cma.j.issn.2095-3224.2022.01.008
Authors:Liang Zhao  Hexue Yuan  Rui Zhang
Affiliation:1. Fifth Department of Anorectal Surgery, Shen Yang Anorectal Hospital,Shenyang 110000, China2. Third Department of Anorectal Surgery, Shen Yang Anorectal Hospital,Shenyang 110000, China3. Department of Colorectal Surgery, Cancer Hospital of Liaoning , Shenyang 110000, China
Abstract:ObjectiveTo observe clinical effect of endorectal advancement flap (ERAF) for the treatment of high complex anal fistula (HCAF). MethodsEighty patients with high complex anal fistula were randomly divided into observation group 40 cases and control group 40 cases. Patients in observation group were treated with ERAF, while those in control group were treated with loose-seton technique (LST). The cure rate, visual analogue pain score (VAS), anal incontinence score (Wexner scale) and recurrence rate of the two groups were analyzed and compared. ResultsThere were no significant differences in the total cure rate, VAS score on the first day after operation (t=-1.268, P>0.05) recurrence rate after 1 year (χ2=1.829, P>0.05). Comparison of two groups:hospital stays (t=-16.464, P<0.05),wound healing time (t=-12.662, P<0.05), VAS scores on the 5th day (t=-8.222, P<0.05)、VAS scores on the 7th day (t=-6.056, P<0.05) after surgery and the Wexner scores (t=-34.785, P<0.05) after recovery. ConclusionERAF can effectively treat high complex anal fistula, and it worthy of being widely used in the clinical treatment of high complex anal fistula to preserve anal sphincter function.
Keywords:Fistula  Endorectal advancement flap  High complex anal fistula  Clinical efficacy  
点击此处可从《中华结直肠疾病电子杂志》浏览原始摘要信息
点击此处可从《中华结直肠疾病电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号